ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a Week
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To determine the satisfaction of subject with Actonel 35 mg Once a Week in the treatment of
post-menopausal osteoporosis. Open, non-controlled, multi-center study.